$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
尼拉帕尼吃多久会有效果
2025-10-19 11:44:20
Check Details
尼拉帕尼奥拉帕尼哪个好
2025-10-19 11:44:20
Check Details
尼拉帕尼多少钱
2025-10-19 11:44:20
Check Details
尼拉帕尼价格贵吗
2025-10-19 11:44:20
Check Details
奥拉帕尼和尼拉帕尼是一种药吗
2025-10-19 11:44:20
Check Details
奥拉帕尼和尼拉帕尼的区别
2025-10-19 11:44:20
Check Details
晚期BRCA突变卵巢癌随访五年,一半患者无疾病进展!
2025-10-19 11:44:20
Check Details
尼拉帕尼一线维持治疗晚期卵巢癌,疾病进展或死亡风险显著降低38%!
2025-10-19 11:44:20
Check Details
SOLO1试验5年随访:奥拉帕尼治疗BRCA突变的晚期卵巢癌效果显著
2025-10-19 11:44:20
Check Details
曲贝替定图片及介绍
2025-10-19 11:44:20
Check Details
曲贝替定多少钱一盒呢?
2025-10-19 11:44:20
Check Details
曲贝替定2020价格
2025-10-19 11:44:20
Check Details
1
2
...
848
849
850
851
852
853
854
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
2
Comprehensive Analysis of the Third-Generation EGFR-TKI
3
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
4
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
5
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
6
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
7
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
8
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
9
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
10
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
11
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
12
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features